Nori Appointed to Cornell Department of Radiation Oncology

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 3
Volume 5
Issue 3

FLUSHING, NY--The New York Hospital-Cornell Medical Center has appointed Dattatreyudu Nori, MD, a pioneer in the subspecialty of brachytherapy, to the position of professor and chairman of the Department of Radiation Oncology.

FLUSHING, NY--The New York Hospital-Cornell Medical Center hasappointed Dattatreyudu Nori, MD, a pioneer in the subspecialtyof brachytherapy, to the position of professor and chairman ofthe Department of Radiation Oncology.

Dr. Nori will remain as professor and chairman of the Departmentof Radiation Oncology and director of Oncology at The New YorkHospital Medical Center of Queens, which is affiliated with theNew York Hospital-Cornell Medical Center and is a member of theNew York Hospital Care Network.

In his new position, Dr. Nori will direct the department's clinicalactivities, its research program, and the training of residentphysicians in radiation oncology.

He will also oversee the administration of the radiation oncologyprograms for the New York Hospital Care Network's 13 member hospitals.The combined network program will be one of the largest in thecountry, providing state-of-the-art radiation treatments to morethan 3,000 new patients each year.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
Related Content